Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, March 11, 2020 (GLOBE NEWSWIRE) -- The "EU Healthcare Predictions and Outlook, 2020" report has been added to ResearchAndMarkets.com's offering. Amid rising global trade...
-
BOSTON, March 11, 2020 (GLOBE NEWSWIRE) -- LogMeIn, Inc. (NASDAQ:LOGM) today announced that its portfolio of Unified Communications & Collaboration products has been positioned as a Leader in...
-
REDWOOD CITY, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Reputation.com, provider of the first and only complete cloud-based enterprise reputation and customer experience management platform, today...
-
FRANKLIN, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- Interactions, LLC, the world’s largest standalone artificial intelligence (AI) company, today announced it has been named to Fast Company’s...
-
WATERTOWN, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services for ambulatory and enterprise customers nationwide, today released a data...
-
FRANKLIN, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- Interactions, LLC, the world’s largest standalone artificial intelligence (AI) company, today announced it has been named to Fast Company’s...
-
Vancouver, BC CANADA, March 10, 2020 (GLOBE NEWSWIRE) -- Hootsuite, a global leader in social media management and Silver level member of OraclePartner Network (OPN), today announced an integration...
-
New Industry Report Pinpoints Consumer Enterprise Brands as Leaders in Journey Management Innovation
BOSTON, March 10, 2020 (GLOBE NEWSWIRE) -- Kitewheel, the provider of the world’s leading customer journey platform, today announced the 2020 release of its annual State of the Customer Journey...
-
London, United Kingdom, March 10, 2020 (GLOBE NEWSWIRE) -- As 2019 drew to a close, the Republic of Armenia’s Ministry of Health signed on as a Member of the SNOMED International community. The...
-
DARE-BV1 demonstrated an 86% clinical cure rate in evaluable subjects at the test-of-cure visit after a single administration in an investigator-initiated proof of concept study, which is higher than...